Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

UBT251

UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)

The United Bio-Technology (Hengqin) Co · Phase 3 · Active, not recruiting · Enrollment 600

NCT07648225

ArmPopulationDoseWeeksEstimandWeight change
UBT251 Injection 4.0 mgObesity or overweight4.0 mg52n/rn/r
UBT251 Injection 6.0 mgObesity or overweight6.0 mg52n/rn/r
UBT251 Injection Placebo 4.0 mgObesity or overweight4.0 mg52n/rn/r
UBT251 Injection Placebo 6.0 mgObesity or overweight6.0 mg52n/rn/r